FFCP PHASE2:Hg19::chr1:200876945..200876972,+
From FANTOM5_SSTAR
Revision as of 02:04, 28 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr1:200876945..200876972, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr1:200876945..200876972, + |
Coexpression cluster: | C302_acute_peripheral_Neutrophils_NK_myelodysplastic_CD34_carcinoid |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr1:200876945..200876972+ |
---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic cell | 3.19e-10 | 177 |
hematopoietic oligopotent progenitor cell | 1.32e-09 | 161 |
hematopoietic multipotent progenitor cell | 1.32e-09 | 161 |
hematopoietic stem cell | 3.83e-09 | 168 |
Showing 1 to 4 of 4 entries
Ontology term | p-value | n |
---|---|---|
leukemia | 9.50e-20 | 39 |
myeloid leukemia | 2.87e-19 | 31 |
hematologic cancer | 6.34e-15 | 51 |
immune system cancer | 6.34e-15 | 51 |
syndrome | 4.53e-14 | 1 |
hematopoietic system disease | 1.12e-07 | 2 |
Showing 1 to 6 of 6 entries